Farm-level risk factors for fluoroquinolone resistance in E. coli and thermophilic Campylobacter spp. on finisher pig farms.
Logistic regression, supported by other statistical analyses was used to explore the possible association of risk factors with the fluoroquinolone (FQ)-resistance status of 108 pig finisher farms in Great Britain. The farms were classified as 'affected' or 'not affected' by FQ-resistant E. coli or Campylobacter spp. on the basis of isolation of organisms from faecal samples on media containing 1 mg/l FQ. The use of FQ was the most important factor associated with finding resistant E. coli and/or Campylobacter, which were found on 79% (FQ-resistant E. coli) and 86% (FQ-resistant Campylobacter) of farms with a history of FQ use. However, resistant bacteria were also found on 19% (FQ-resistant E. coli) and 54% (FQ-resistant Campylobacter) of farms with no history of FQ use. For FQ-resistant E. coli, biosecurity measures may be protective and there was strong seasonal variation, with more farms found affected when sampled in the summer. For FQ-resistant Campylobacter, the buying-in of grower stock may increase risk and good on-farm hygiene may be protective. The findings suggest that resistant organisms, particularly Campylobacter, may spread between pig farms.
Taylor
N M
NM
School of Agriculture, Policy and Development, University of Reading, Reading, Berkshire, UK. n.m.taylor@reading.ac.uk
Clifton-Hadley
F A
FA
Wales
A D
AD
Ridley
A
A
Davies
R H
RH
D000382:Agricultural Workers' Diseases / Q000382:microbiology*; D000822:Animal Husbandry; D000818:Animals; D002167:Campylobacter / Q000187:drug effects* / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000635:transmission; D002353:Carrier State / Q000382:microbiology* / Q000635:transmission; D003430:Cross-Sectional Studies; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000635:transmission; D024841:Fluoroquinolones / Q000627:therapeutic use*; D012307:Risk Factors; D034421:Sus scrofa; D006113:United Kingdom
D024841:Fluoroquinolones